Search research articles
Contact Us
Filters
Showing results (651-660 of 934) with videos related to
Page
of 94
Sort By:
Journal of the American Heart Association
|
January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Clare Arnott, Qiang Li, Amy Kang, et al.
European Heart Journal
|
February 23, 2019
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
Jonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, et al.
The American Journal of Cardiology
|
April 4, 1998
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia
S Borzak, C P Cannon, P L Kraft, et al.
The American Journal of Cardiology
|
January 12, 2005
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction
Ajay J Kirtane, Aaron Weisbord, Dimitrios Karmpaliotis, et al.
Immunity
|
August 5, 2008
A bony fish immunological receptor of the NITR multigene family mediates allogeneic recognition
John P Cannon, Robert N Haire, Andrew T Magis, et al.
The American Journal of Cardiology
|
November 3, 2004
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction
Dimitrios Karmpaliotis, Minang P Turakhia, Ajay J Kirtane, et al.
American Heart Journal
|
October 11, 2011
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome
William B White, George L Bakris, Richard M Bergenstal, et al.
Journal of the American Heart Association
|
January 13, 2017
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial
Alon Eisen, Christopher P Cannon, Eugene Braunwald, et al.
The American Journal of Cardiology
|
September 6, 2018
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status
Andrew P Ambrosy, Lukasz P Cerbin, Marat Fudim, et al.
Clinical Cardiology
|
June 30, 2012
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program
Samip Vasaiwala, Christopher P Cannon, Gregg C Fonarow, et al.
Page
of 94
Search research articles
Search
Showing results (651-660 of 934) with videos related to
Sort By:
Page
of 94
Journal of the American Heart Association
|
January 30, 2020
Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
Clare Arnott, Qiang Li, Amy Kang, et al.
European Heart Journal
|
February 23, 2019
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial
Jonas Oldgren, Philippe Gabriel Steg, Stefan H Hohnloser, et al.
The American Journal of Cardiology
|
April 4, 1998
Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia
S Borzak, C P Cannon, P L Kraft, et al.
The American Journal of Cardiology
|
January 12, 2005
Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction
Ajay J Kirtane, Aaron Weisbord, Dimitrios Karmpaliotis, et al.
Immunity
|
August 5, 2008
A bony fish immunological receptor of the NITR multigene family mediates allogeneic recognition
John P Cannon, Robert N Haire, Andrew T Magis, et al.
The American Journal of Cardiology
|
November 3, 2004
Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction
Dimitrios Karmpaliotis, Minang P Turakhia, Ajay J Kirtane, et al.
American Heart Journal
|
October 11, 2011
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome
William B White, George L Bakris, Richard M Bergenstal, et al.
Journal of the American Heart Association
|
January 13, 2017
Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial
Alon Eisen, Christopher P Cannon, Eugene Braunwald, et al.
The American Journal of Cardiology
|
September 6, 2018
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status
Andrew P Ambrosy, Lukasz P Cerbin, Marat Fudim, et al.
Clinical Cardiology
|
June 30, 2012
Quality of care and outcomes among patients with acute myocardial infarction by level of kidney function at admission: report from the get with the guidelines coronary artery disease program
Samip Vasaiwala, Christopher P Cannon, Gregg C Fonarow, et al.
Page
of 94